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Abstract:  Over  the  past  30  years,  genomic  and  bioinformatic  analysis  of  human 
adenoviruses has been achieved using a variety of DNA sequencing methods; initially with 
the  use  of  restriction  enzymes  and  more  currently  with  the  use  of  the  GS  FLX 
pyrosequencing technology. Following the conception of DNA sequencing in the 1970s, 
analysis  of  adenoviruses  has  evolved  from  100  base  pair  mRNA  fragments  to  entire 
genomes. Comparative genomics of adenoviruses made its debut in 1984 when nucleotides 
and amino acids of coding sequences within the hexon genes of two human adenoviruses 
(HAdV), HAdV–C2 and HAdV–C5, were compared and analyzed. It was determined that 
there were three different zones (1-393, 394-1410, 1411-2910) within the hexon gene, of 
which HAdV–C2 and HAdV–C5 shared zones 1 and 3 with 95% and 89.5% nucleotide 
identity, respectively. In 1992, HAdV-C5 became the first adenovirus genome to be fully 
sequenced using the Sanger method. Over the next seven years, whole genome analysis 
and  characterization  was  completed  using  bioinformatic  tools  such  as  blastn,  tblastx, 
ClustalV and FASTA, in order to determine key proteins in species  HAdV-A through  
HAdV-F.  The  bioinformatic  revolution  was  initiated  with  the  introduction  of  a  novel 
species, HAdV-G, that was typed and named by the use of whole genome sequencing and 
phylogenetics as opposed to traditional serology. HAdV bioinformatics will continue to 
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advance as the latest sequencing technology enables scientists to add to and expand the 
resource databases. As a result of these advancements, how novel HAdVs are typed has 
changed. Bioinformatic analysis has become the revolutionary tool that has significantly 
accelerated the in-depth study of HAdV microevolution through comparative genomics. 
Keywords: human adenoviruses; genomics; bioinformatics 
 
1. Introduction 
Genomics and bioinformatics have provided a highly detailed understanding of organisms through 
the analysis of primary sequence data. With the rapid adoption and continuing improvement of next 
generation DNA sequencing technology and methodology, understanding the biology and pathology 
of human pathogens is tantalizingly within reach. Viruses, especially human adenoviruses, are an 
important model for defining both the biology and pathology based on the primary sequence data, due 
to  their genome size and importance as human pathogens. In this  review  we provide a historical 
perspective of how the genomic and bioinformatic analyses of human adenoviruses (HAdVs) have 
advanced in the last 30 years. We start by describing the first few nucleotides that were sequenced 
using both the Maxam-Gilbert and the Sanger sequencing methods, then the first complete genes as 
well as the first whole adenovirus genome to be assembled and analyzed. Initially, the genomes were 
sequenced  in  parts  from  different  laboratories  and  using  different  methods,  and  assembled  as  a 
complete  but  mosaic  contribution.  As  noted,  some  of  these  data,  including  whole  genomes,  for 
example HAdV-D17, contain sequencing errors that hinder comparative genomic analysis. Currently, 
technologies  such  as  the  GS  FLX  pyrosequencing  method  provide  definitive  single  laboratory-
initiated and single method high-quality genomes. The major advances in the bioinformatic analysis of 
adenoviruses will also be discussed, with highly detailed snapshots of human adenoviruses in general, 
pathology and molecular evolution of new types and emerging or re-emerging pathogens. This review 
ends with a description of the current state of adenovirus bioinformatics and developing trends. 
2. The Labor of Human Adenovirus Genomics 
In the beginning of adenoviral genomics, positions within the human adenovirus (HAdV) type 2 
genome were mapped using restriction enzyme analysis [1]. A few years later, upon the advent of 
DNA sequencing by Maxam and Gilbert [2], 139 base pairs of the mRNA leading up to the 5’ region 
of  the  hexon  gene  was  determined  [3].  Benefits  of  this  work  included  visualization  of  the  two-
dimensional nucleotide structure of the HAdV-C2 promoter, and a hypothetical determination of the 
secondary structure in the associated mRNA.  
First Example of Comparative Genomics in Human Adenoviruses 
As an early demonstration of comparative genomics, the hexon genes of HAdV-C2 and HAdV-C5 
were the first two human adenovirus genes to be compared to one another [4]. In that study, analysis 
of the nucleotides and amino acids of the two hexon coding sequences demonstrated that the hexon Viruses 2010, 2                                       
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gene could be divided up into three different zones (1-393, 394-1410, 1411-2910). Zones 1 and 3 in 
the hexon genes of HAdV-C2 and HAdV-C5 had 95% and 89.5% nucleotide identity, respectively  
(Figure 1A) [4]. The nucleotide identity of the two genes diverged in zone 2 (Figure 1A). Today, zone 
2 is recognized as the  determinant, which contains the type-specific epitopes of the hexon gene 
(Figure 1B). 
Figure 1.  Analysis of the hexon gene. (a) A Nucleotide homology between the hexon 
coding sequences of HAdV-C2 and HAdV-C5. zPicture was used to compare the whole 
genomes for regions of homology/similarity. Along the y-axis, the baseline is set at 50% 
nucleotide identity and the top line is set at 100%; the entire gene length is displayed on 
the  x-axis.  (b)  Schematic  of  the  hexon  protein.  Variable  regions  V1,  V2,  and  V3  are 
located in loops 1 and 2 and are outwardly oriented on the surface of the adenovirus 
particle. The epsilon () fragment includes regions V1, C2, V2, C3, and V3. 
 
 
3. The Birth of Human Adenovirus Genomics 
3.1. HAdV-C2: The First HAdV Sequenced 
Human adenovirus genomics was born in 1984 when Roberts and coworkers amalgamated pieces 
of the HAdV-C2 genome, sequenced in separate laboratories during different time periods, and with 
dissimilar methods, to present whole and complete genome analysis (Figure 2A) [5]. Prior to the entire 
HAdV-C2  sequence  being  deduced  as  35,937  nucleotides,  the  locations  of  genes  in  adenovirus 
genomes were described using a map unit system [1]. After the HAdV-C2 genome was analyzed, a 
coordinate system was introduced where 1% of the genome equaled 365 nucleotides [5]. However, 
since adenovirus genomes differ in length, this methodology did not stand the test of time. Viruses 2010, 2                                       
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Figure 2. Transcriptional map and genome organization of HAdV-C2, HAdV-F40, and 
HAdV-D53. Genomes are represented by a central black horizontal line marked at 5-kbp 
intervals.  Protein  encoding  regions  are  shown  as  boxes.  Boxes  above  the  black  line 
represent open reading frames (ORFs) that are encoded on the forward (or upper) strand. 
Boxes underneath the black line represent ORFs that are encoded on the reverse (or lower) 
strand. (a) HAdV-C2. (b) HAdV-F40. (c) HAdV-D53. Figure 2B was adapted from Walsh 
et al., 2009 with permission [6]. 
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3.2. HAdV-C5 
Although  it  was  a  piecemeal  effort,  eight  years  later,  the  whole  genome  of  HAdV-C5  was 
determined  using  Sanger  sequencing  (Table  1).  This  accomplishment  was  significant  because  it 
allowed for direct genomic comparison between two adenoviral genomes [7]. Comparative analysis of 
the  HAdV-C2  and  HAdV-C5  genomes  demonstrated  that  the  genes  with  the  greatest  amino  acid 
differences were the hexon, fiber, and the 19K ORF located in the E3 gene. This has since been 
confirmed and updated by pairwise alignment of multiple HAdV genomes from all known species 
sequenced to date [8]. 
In the next seven years, three adenovirus genomes (HAdV-F40, HAdV-A12, HAdV-D17) were 
sequenced and deposited in GenBank (Table 1). Bioinformatic analysis of the HAdV-F40 genome 
revealed several features not seen previously in a human adenovirus: two fiber genes and the U protein 
(Figure 2B) [9]. The percent identities of key proteins in species HAdV-A through HAdV-F, as well 
as other animal adenoviruses, were compared. Since HAdV-A12 was the first whole genome to be 
sequenced  from  species  HAdV-A  (Table  1),  Sprengel  and  colleagues  compared  it  to  HAdV-C2. 
Comparison of the HAdV-A12 and HAdV-C2 genomes was innovative in that it was the first instance 
where powerful bioinformatic tools such as blastn, tblastx, ClustalV, and FASTA were used on whole 
adenovirus genomes [10]. The use of ClustalV was ground-breaking in that it allowed researchers the 
opportunity to view the overall similarity of two genomes, on the nucleotide level, in one figure [10]. 
This  led  to  the  finding  that  the  HAdV-A12  and  HAdV-C5  genomes  have  the  highest  nucleotide 
identity  in  the  5000–8000  base  pair  (bp)  region  (DNA  polymerase).  The  remaining  members  of 
species HAdV-A, HAdV-A18 and HAdV-A31, were recently sequenced and analyzed [11,12]. 
3.3. Illegitimate Recombination Offered as a Possible Mechanism for Molecular Evolution 
In 1996, Crawford-Miksa and Schnurr postulated that adenovirus molecular evolution is expedited 
by illegitimate recombination in the hexon gene of human adenoviruses due to slippage of the HAdV 
DNA polymerase in repetitive polypurine stretches [13]. This provided a plausible model as to how a 
species of viruses with a stable DNA genome has the potential to evolve over a short period of time. 
Bioinformatic analysis has revealed that the neutralization determinants are located in two loops that 
cover the surface of adenoviruses in the hexon gene (Figure 1B) [13,14] and that recombination is 
highly structured [6,15-17]. These studies were important because they helped scientists visualize how 
human adenoviruses could evolve. 
3.4. HAdV-B11 
In 2003, the HAdV-B11 genome was the first HAdV from species HAdV-B to be completely 
sequenced [18,19]. As human adenoviruses are important vectors in human gene therapy trials, other 
HAdV genomes have been sequenced and archived in GenBank. The HAdV-B11 genome studies 
marked  the  first  time  that  phylogenetic  analysis  was  used  to  examine  the  relationships  between 
homologous genes from all HAdV species.  
Traditionally,  HAdVs,  as  highly  contagious  respiratory  pathogens,  have  been  of  immediate 
concerns to military populations, particularly basic training personnel [20,21]. In the 1970s, vaccines Viruses 2010, 2                                       
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against HAdV types 4 and 7 were produced, validated and deployed [22,23]. These vaccines were 
successful in preventing respiratory diseases, particularly acute respiratory disease outbreaks in the 
U.S. for over 20 years [22,23]. The manufacture and deployment of these vaccines were discontinued 
in the 1990s. Soon after production of vaccines against HAdV-E4 and HAdV-B7 ceased in 1997, an 
outbreak of HAdV-E4 erupted at Fort Jackson [24], causing unexpected and highly contagious acute 
respiratory disease. The re-emergence of epidemic outbreaks of febrile respiratory infections caused 
by infection with HAdV-E4 and HAdV-B7 among basic military trainees was of immediate pressing 
concern  to  the  U.S.  Department  of  Defense,  which  led  to the creation of the Epidemic Outbreak 
Surveillance (EOS) Consortium, as a program funded in part and sponsored by the Office of the U.S. 
Air Force Surgeon General. As part of an effort to redevelop the HAdV-E4 and HAdV-B7 vaccines 
and to develop molecular surveillance platforms for respiratory disease pathogen detection, the EOS 
Consortium sequenced 17 genomes of HAdVs, including the vaccine strains for HAdV-E4vac and 
HAdV-B7vac [25] as well as both the HAdV-E4 [26] and HAdV-B7 reference genome [25]. To gain a 
greater understanding of HAdVs in the species HAdV-B, EOS also sequenced prototypes HAdV-C1 
[27],  HAdV-B3,  HAdV-B16,  HAdV-B21,  HAdV-B34,  HAdV-B50  and  HAdV-C6,  more  than 
doubling  the  number  of  completely  sequenced  genomes  at  the  time.  Additional  contemporary 
circulating field strains of aforementioned HAdVs were also sequenced. 
Analysis of the HAdV-E4vac and HAdV-B7vac genomes was a turning point in bioinformatic and 
genomic investigation, because the genomes of both viruses were compared and contrasted with field 
strains within the same species as opposed to HAdV-C2 or HAdV-C5, with a fine nucleotide-level 
granularity. Additionally, the implications for all insertions/deletions (indels), larger gaps, and single 
base substitutions in HAdV-E4 and HAdV-B7 were discussed [26]. 
Table 1. Timeline of HAdV sequencing. 
HAdV  Year sequenced  Reference 
HAdV-C2  1984  [5] 
HAdV-C5  1992  [7] 
HAdV-F40  1993  [9] 
HAdV-A12  1994  [10] 
HAdV-D17  1999  NP 
HAdV-B11 
 
HAdV-B35 
2003  [18] 
[19] 
[28] 
[29] 
HAdV-C1 
HAdV-D9 
HAdV-B16 
HAdV-B21 
HAdV-B34 
HAdV-B50 
2004  [27] 
NP 
NP 
NP 
NP 
NP 
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Table 1. Cont. 
HAdV  Year sequenced  Reference 
HAdV-E4 
HAdV-B7 
HAdV-F41 
2005  [26] 
[26] 
NP 
HAdV-B3 
 
HAdV-D26 
HAdV-D46 
HAdV-D48 
HAdV-D49 
2006  [30] 
[31] 
NP 
NP 
NP 
NP 
HAdV-G52  2007  [32] 
HAdV-D37 
HAdV-D19 
2008  [8] 
[33] 
HAdV-B14 
HAdV-D8 
HAdV-D22 
HAdV-D28 
HAdV-A31 
HAdV-D53 
HAdV-D54 
2009  [34] 
NP 
[16] 
NP 
[35] 
[6] 
[36] 
HAdV-A18 
HAdV-D36 
HAdV-B55 
2010  [12] 
[37] 
[17] 
NP – not published. 
 
In  2006,  five  additional  HAdV  genomes  (HAdV-F41,  HAdV-D26,  HAdV-D46,  HAdV-D48, 
HAdV-D49) were sequenced and posted in GenBank (Table 1). However, their genomes were not 
fully analyzed in peer-reviewed articles. Nevertheless, their availability in GenBank allows their use 
for comparison to other HAdV genomes. 
4. Major Advances in the Bioinformatic Revolution of Human Adenoviruses 
4.1. HAdV-G52 
The  discovery  of  HAdV-G52  marked  the  beginning  of  the  bioinformatic  revolution  in 
understanding human adenoviruses from a primary sequence perspective. Not only was this event 
significant  because  a  new  species  (HAdV-G)  was  introduced,  but  it  was  the  first  time  a  new 
adenovirus type and species were proclaimed by whole genome sequencing, as opposed to serology 
[32].  However,  this  was  not  without  controversy  as  the  announcement  of  the  first  adenovirus 
discovery in the 21st century was challenged, albeit unsuccessfully [38]. Not only has HAdV-G52 Viruses 2010, 2                                       
 
 
1374 
been accepted as the 52nd type of human adenovirus, but the new species HAdV-G has also been 
accepted by the International Congress of Virology and Taxonomy. 
4.2. Simplot Analysis of Novel Adenovirus in Species HAdV-C 
Lukashev and coworkers were the first group to use bootscan and Simplot analysis to analyze 
partially sequenced adenovirus genomes for recombination. Using these powerful tools, they found 
that recombination is frequent in adenovirus species HAdV-B, -C, and -D [15]. Interestingly, they 
found one clinical isolate (strain #16700) from species HAdV-C that had high amino acid identity to 
the  fiber  gene  of  HAdV-C6  and  a  hexon  gene  that  was  distinct  from  all  viruses  in  species  
HAdV-C [15]. Moreover, strain #16700 could not be serotyped unambiguously in a neutralization test 
and most likely represents a novel type within species HAdV-C. Bootscan analysis of the 3’ end of the 
#16700  strain  genome  (nucleotides  18838–33452)  demonstrated  multiple  recombination  events. 
However, the location of the recombination breakpoints was not pinpointed. 
4.3. HAdV-D53 
In the previous decade it was cost-prohibitive to sequence entire adenoviral genomes; thus, to 
properly declare a novel adenovirus, one had to use all of the known antisera that reacted against the 
known  adenoviruses  [39].  When  an  adenovirus  was  neutralized  by  antisera  dissimilar  to  its 
hemagglutination profile, it was erroneously named an intermediate recombinant [40]. Without the 
complete genome sequence it was impossible to know where putative recombination events occurred. 
Today, sequencing a complete adenovirus genome is much cheaper and more efficient, and is of higher 
quality than in 1984. Bioinformatic analysis of fully sequenced recombinant adenoviruses has made it 
possible  to  determine  the  exact  loci  of  recombination.  Such  was  the  case  when  HAdV-D53  was 
characterized  using  genomics  and  bioinformatics  [6].  HAdV-D53  was  initially  described  as 
intermediate HAdV-D22.H8, because partial sequencing of the hexon gene revealed 100% identity to 
the  HAdV-D22  hexon  sequence  and  it  was  assumed  that  the  rest  of  the  genome  would  yield  
HAdV-D22 as well. The H8 was ascribed to this proposed intermediate when the fiber sequence was 
found to be identical to that of HAdV-D8 [40]. To elucidate the origin of the novel sequence, Walsh 
and colleagues sequenced the whole genome and found adenoviral sequences from known, as well as 
unknown (or as yet unsequenced), adenoviruses (Figure 2C) [6]. In the same study it was also shown 
that recombination within the hexon gene is common in species HAdV-D and that HAdV-D53, as an 
emergent,  highly  contagious  keratoconjunctivitis-causing  pathogen,  was  created  by  multiple 
recombination events. Specifically, it was shown that the recombination events in the hexon occur at 
the beginning and the end of the epsilon fragment (Figure 3).  
4.4. Recombination is Common in the Penton Gene of Species HAdV-D 
Recently  the  genome  of  HAdV-D22  was  completely  sequenced.  Analysis  of  the  penton  gene 
confirmed that there were recombination events in two external hypervariable loops in the penton 
coding sequence, encompassing nucleotides 400-600 and 750-1350, which are located on the exposed 
area  of  the  viral  capsid  [16].  These  recombination  events  were  also  seen  in  the  penton  genes  of  Viruses 2010, 2                                       
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HAdV-D9 and HAdV-D26, demonstrating that the aforementioned areas represent recombination hot 
spots within species HAdV-D.  
Figure 3. Model of recombination for human adenoviruses. Recombination in the hexon 
gene of HAdVs is hypothesized to occur around nucleotide positions 380 and 1500. These 
positions  frame  the  neutralization  determinants  (epsilon    fragment)  of  HAdVs.  These 
positions  are  also  demarcated  by  white  arrows.  The  indicated  nucleotide  positions  are 
based on HAdV-D53 [6]. 
 
 
4.5. Hypothetical Recognition Sites for Recombination in the Hexon Gene 
It  is  possible  that  human  recombinase  proteins have a propensity to bind certain sequences in 
adenovirus genomes. After analyzing aligned HAdV-D hexon sequences, we saw a motif that was 
common  at  the  beginning  and  end  of  the  epsilon  fragment  (Figure  4).  Because  we  do  not  have 
biological data to confirm this observation, we acknowledge that further studies will be required to 
prove such a hypothesis. 
4.6. HAdV-B55 
Currently, there are 55 recognized types of HAdVs [17,41]; the term “type” is used to include 
original  serotypes  1-51,  determined  using  traditional  serology,  as  well  as  the  additional  four 
genotypes,  characterized  using  genomics  and  bioinformatics.  HAdV-B55,  provisionally  named 
HAdV-B11.QS, was isolated in China from a patient who died of an acute respiratory disease-induced 
multiple organ failure [42]. HAdV-B55 was recognized as a new human adenovirus when Walsh et al. 
presented comprehensive nucleotide sequence evidence that the HAdV-B11.QS genome was actually Viruses 2010, 2                                       
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97.4% identical to HAdV-B14, with the remaining 2.6% derived from HAdV-B11. Further analysis 
demonstrated that the only part of the HAdV-B11.QS genome that had high homology to HAdV-B11 
was the epsilon fragment in the hexon gene (Figure 5), accounting for the initial serological-based 
characterization as HAdV-B11. 
Figure 4. Hypothetical recognition sites for recombination in the hexon gene. Rectangular 
boxes  represent  hypothesized  recognition  sites,  which  are  recognized  by  hypothetical 
recombinase. Red and yellow ovals are hypothesized recombinase proteins. 
 
 
Figure  5.  Fine-resolution bootscan analysis demonstrating recombination in the partial 
hexon gene of HAdV-B55. Bootscan analysis of the hexon gene shows that the proximal 
region,  containing  Loops  1  and  2,  is  derived  from  HAdV-B11.  The  distal  portion  is 
derived from HAdV-B14, as is the remainder of the HAdV-B55 genome. Parameters are as 
follows: 200-bp window; 20-bp step; 100 repetitions; neighbor-joining algorithm. This 
figure was adapted from Walsh et al., 2010 with permission [17]. 
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5. The Future 
Further advancements in HAdV bioinformatics are expected as sequencing technology provides us 
a large number of genomes as resources. We expect these advances to develop our understanding of 
the  microevolution  of  HAdVs.  For  example,  the  GS-FLX  is  currently  able  to  sequence  400-600 
million bases per run. With the recent publication of HAdV-D36 [37], there are only 20 remaining 
HAdV  types  (720  kb  of  viral  genomic  DNA)  still  unsequenced,  all  within  species  HAdV-D. 
Theoretically, all of the unsequenced HAdVs could be completely sequenced in one run on the GS 
FLX Titanium with 833-fold coverage of each genome, ensuring high quality data.  
Advances in sequencing technology have also led to necessary changes in HAdV nomenclature. 
All of the HAdVs that have been discovered/characterized in the 21st century have been numbered 
without utilizing exhaustive serology [6,17,32,41]. Novel HAdVs should now be named in one of two 
ways.  If  a  new  HAdV  is  suspected,  the  whole  genome  should  be  sequenced  and  analyzed  via 
phylogenetic analysis. If the proposed HAdV consistently falls into a different lineage than all other 
HAdV  species,  as  was  the  case  for  HAdV-G52,  then  identification  of  a  new  HAdV  species  and 
number is justified. If phylogenetics place the virus in an existing species, but it is sufficiently distinct 
from other members of that species, and/or recombinant in a way that impacts the tropism or extent of 
disease, the virus would be considered novel and deserving of a new type number. A second method is 
traditional serology: if the proposed new virus cannot be neutralized by any of the known antisera, 
then it can be considered as novel and assigned a new number. Ideally, the characterization of any 
HAdV as new should include whole genome sequencing and bioinformatics analysis. 
6. Conclusions 
Advances in sequencing technology have increased the number of human adenoviruses that are 
currently available for comparative analysis. These advances have elucidated our understanding of the 
molecular evolution of HAdVs. Our clearer comprehension of HAdV genomics has also given birth to 
changes in how we type and number novel HAdVs. Since 35 of 55 HAdV genomes have been fully 
sequenced  and  analyzed,  we  know  that  (a)  much  of  the  HAdV  genome  is  conserved,  (b)  the  
non-conserved  regions  are  restricted  to  the  penton,  hexon,  E3,  and  the  fiber  genes,  and  that  (c) 
recombination is a common occurrence at critical loci in the penton and hexon genes of viruses in 
species HAdV-D. We do not know which enzymes are involved in facilitating recombination, the 
specific sequences that are recognized, why recombination appears to occur at a faster rate in species 
HAdV-D than other species, or the loci of other recombination hot spots within the HAdV genome. 
The characterization and discovery of novel HAdVs, as well as the genetic analysis of the 20 HAdVs 
which remain to be sequenced (Table 2), will increase our understanding of HAdV genomics. Viruses 2010, 2                                       
 
 
1378 
Table 2. Human adenoviruses that have not been completely sequenced. 
HAdV  ATCC number 
HAdV-D10  VR-1087 
HAdV-D13  VR-14 
HAdV-D15  VR-16 
HAdV-D20  VR-255 
HAdV-D23  VR-258 
HAdV-D24  VR-259 
HAdV-D25  VR-223 
HAdV-D27  VR-1105 
HAdV-D28  VR-226 
HAdV-D29  VR-272 
HAdV-D30  VR-273 
HAdV-D32  VR-625 
HAdV-D33  VR-626 
HAdV-D38  VR-988 
HAdV-D39  VR-932 
HAdV-D42  VR-1304 
HAdV-D44  VR-1306 
HAdV-D45  VR-1307 
HAdV-D47  VR-1309 
HAdV-D51  VR-1603 
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